Total Equity - InterCure Ltd (NASDAQ:INCR) - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InterCure Ltd
Total Equity Peer Comparison

Comparables:
TEVA
RDHL
SLGL
MDWD
R
REKA

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
NASDAQ:INCR
Total Equity
â‚Ş455.1m
CAGR 3-Years
18%
CAGR 5-Years
87%
CAGR 10-Years
61%
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Total Equity
$6.4B
CAGR 3-Years
-15%
CAGR 5-Years
-15%
CAGR 10-Years
-12%
Redhill Biopharma Ltd
NASDAQ:RDHL
Total Equity
$61k
CAGR 3-Years
-87%
CAGR 5-Years
-71%
CAGR 10-Years
-47%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Total Equity
$34.9m
CAGR 3-Years
-4%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Total Equity
$17.9m
CAGR 3-Years
104%
CAGR 5-Years
0%
CAGR 10-Years
-10%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Total Equity
â‚Ş156.8m
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
7%

See Also

What is InterCure Ltd's Total Equity?
Total Equity
455.1m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Total Equity amounts to 455.1m ILS.

What is InterCure Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
61%

Over the last year, the Total Equity growth was -9%. The average annual Total Equity growth rates for InterCure Ltd have been 18% over the past three years , 87% over the past five years , and 61% over the past ten years .

Back to Top